Adriana Cardozo

2.5k total citations
27 papers, 832 citations indexed

About

Adriana Cardozo is a scholar working on Neurology, Cellular and Molecular Neuroscience and Physiology. According to data from OpenAlex, Adriana Cardozo has authored 27 papers receiving a total of 832 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Neurology, 10 papers in Cellular and Molecular Neuroscience and 8 papers in Physiology. Recurrent topics in Adriana Cardozo's work include Parkinson's Disease Mechanisms and Treatments (14 papers), Alzheimer's disease research and treatments (6 papers) and Genetic Neurodegenerative Diseases (5 papers). Adriana Cardozo is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (14 papers), Alzheimer's disease research and treatments (6 papers) and Genetic Neurodegenerative Diseases (5 papers). Adriana Cardozo collaborates with scholars based in Spain, United Kingdom and United States. Adriana Cardozo's co-authors include Eduardo Tolosa, M. Rey, Isidró Ferrer, Berta Puig, Mario Ezquerra, Teresa Ribalta, Rosa Blanco, Francesc Viñals, E. Goutan and Margarita Carmona and has published in prestigious journals such as Journal of Neurology Neurosurgery & Psychiatry, Acta Neuropathologica and Movement Disorders.

In The Last Decade

Adriana Cardozo

26 papers receiving 813 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Adriana Cardozo Spain 16 403 294 222 214 210 27 832
Justin Kwan United States 14 614 1.5× 260 0.9× 211 1.0× 272 1.3× 214 1.0× 32 1.3k
E. Kapaki Greece 15 308 0.8× 359 1.2× 198 0.9× 178 0.8× 262 1.2× 24 893
T. Bird United States 12 286 0.7× 358 1.2× 128 0.6× 305 1.4× 145 0.7× 16 904
Gareth W. Roberts United Kingdom 8 213 0.5× 296 1.0× 214 1.0× 291 1.4× 88 0.4× 9 838
C Duyckaerts France 15 217 0.5× 180 0.6× 170 0.8× 157 0.7× 146 0.7× 53 642
Martha Foiani United Kingdom 18 256 0.6× 408 1.4× 153 0.7× 312 1.5× 158 0.8× 23 855
Francesca Magrinelli Italy 14 466 1.2× 164 0.6× 201 0.9× 107 0.5× 84 0.4× 51 784
Sebastián Cervantes Spain 15 139 0.3× 213 0.7× 89 0.4× 163 0.8× 144 0.7× 16 585
Giovanni Palermo Italy 14 370 0.9× 147 0.5× 141 0.6× 142 0.7× 98 0.5× 45 622
H. Mejía United States 8 682 1.7× 175 0.6× 251 1.1× 72 0.3× 123 0.6× 9 847

Countries citing papers authored by Adriana Cardozo

Since Specialization
Citations

This map shows the geographic impact of Adriana Cardozo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Adriana Cardozo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Adriana Cardozo more than expected).

Fields of papers citing papers by Adriana Cardozo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Adriana Cardozo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Adriana Cardozo. The network helps show where Adriana Cardozo may publish in the future.

Co-authorship network of co-authors of Adriana Cardozo

This figure shows the co-authorship network connecting the top 25 collaborators of Adriana Cardozo. A scholar is included among the top collaborators of Adriana Cardozo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Adriana Cardozo. Adriana Cardozo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Youn, Jinyoung, Jong Hyeon Ahn, Oluwadamilola O. Ojo, et al.. (2025). The Feasibility and Practical Utility of Virtual Visits for Patients with Parkinson's Disease in Different World Regions. Movement Disorders Clinical Practice. 13(2). 419–429.
2.
Cubo, Esther, Álvar Arnaiz‐González, José-Francisco Díez-Pastor, et al.. (2021). Videoconferencing Software Options for Telemedicine: A Review for Movement Disorder Neurologists. Frontiers in Neurology. 12. 745917–745917. 11 indexed citations
3.
Hassan, Anhar, Zoltán Mari, Emilia Gatto, et al.. (2020). Global Survey on Telemedicine Utilization for Movement Disorders During the COVID‐19 Pandemic. Movement Disorders. 35(10). 1701–1711. 63 indexed citations
4.
Gaig, Carles, Marı́a José Martı́, Mario Ezquerra, et al.. (2009). G2019S LRRK2 mutation causing Parkinson’s disease without Lewy bodies. BMJ Case Reports. 2009. bcr0820080632–bcr0820080632. 14 indexed citations
5.
Pujols, Laura, Joaquim Mullol, Jordi Roca‐Ferrer, et al.. (2008). Relevance of COX‐2 gene expression in dementia with lewy bodies associated with Alzheimer pathology. Movement Disorders. 23(6). 804–810. 8 indexed citations
6.
Gaig, Carles, Mario Ezquerra, Marı́a José Martı́, et al.. (2008). Screening for the LRRK2 G2019S and codon-1441 mutations in a pathological series of parkinsonian syndromes and frontotemporal lobar degeneration. Journal of the Neurological Sciences. 270(1-2). 94–98. 31 indexed citations
7.
Rodríguez, José, Klaus Seppi, Adriana Cardozo, et al.. (2007). Cerebrospinal fluid hypocretin‐1 levels in multiple system atrophy. Movement Disorders. 22(12). 1822–1824. 23 indexed citations
8.
Gaig, Carles, Marı́a José Martı́, Mario Ezquerra, et al.. (2007). G2019S LRRK2 mutation causing Parkinson's disease without Lewy bodies. Journal of Neurology Neurosurgery & Psychiatry. 78(6). 626–628. 81 indexed citations
9.
Holmberg, Björn, Per Johansson, Werner Poewe, et al.. (2007). Safety and tolerability of growth hormone therapy in multiple system atrophy: A double‐blind, placebo‐controlled study. Movement Disorders. 22(8). 1138–1144. 43 indexed citations
10.
Katzenschlager, Regina, et al.. (2003). Unclassifiable parkinsonism in two European tertiary referral centres for movement disorders. Movement Disorders. 18(10). 1123–1131. 19 indexed citations
11.
Ferrer, Isidró, Merçé Boada, M. Rey, et al.. (2003). Primary progressive aphasia as the initial manifestation of corticobasal degeneration and unusual tauopathies. Acta Neuropathologica. 106(5). 419–435. 57 indexed citations
12.
Muñoz, Esteban, María Jesús Buxó ì Rey, Montserrat Milà, et al.. (2002). Intranuclear inclusions, neuronal loss and CAG mosaicism in two patients with Machado–Joseph disease. Journal of the Neurological Sciences. 200(1-2). 19–25. 30 indexed citations
13.
Procianoy, Renato S., et al.. (1996). Evaluation of umbilical cord pH and its relationship with Apgar score in term newborn infants. Jornal de Pediatria. 72(3). 139–142. 5 indexed citations
14.
Cruz-Sánchez, F. F., Adriana Cardozo, & E. Tolosa. (1995). Neuronal Changes in the Substantia Nigra with Aging. Journal of Neuropathology & Experimental Neurology. 54(1). 74–81. 21 indexed citations
15.
Cardozo, Adriana, et al.. (1993). Migraine: An Alternative in the Diagnosis of Unclassified Vertigo. Headache The Journal of Head and Face Pain. 33(3). 125–128. 34 indexed citations
16.
Cruz-Sánchez, Felix, Adriana Cardozo, Santiago Ambrosio, Eduardo Tolosa, & Nicole Mahy. (1993). Plasticity of the nigrostriatal system in MPTP-treated mice. Molecular and Chemical Neuropathology. 19(1-2). 163–176. 14 indexed citations
17.
Palacı́n, Antonio, Adriana Cardozo, Antonio Cardesa, & F. F. Cruz-Sánchez. (1993). Brain banks and non nervous tissues.. PubMed. 39. 87–96. 1 indexed citations
18.
Cruz-Sánchez, Felix, et al.. (1992). Ubiquitin in cerebral amyloid angiopathy. Journal of the Neurological Sciences. 112(1-2). 46–50. 12 indexed citations
20.
Cruz-Sánchez, Felix, et al.. (1992). Immunohistological study of grumose degeneration of the dentate nucleus in progressive supranuclear palsy. Journal of the Neurological Sciences. 110(1-2). 228–231. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026